a) Administration of Psychotropic Medication
1) Psychotropic medication shall not be
administered to any youth against his or her will or without the consent of the
parent or guardian of a minor who is under the age of 18, unless:
A) A psychiatrist, or in the absence of a
psychiatrist a physician, has determined that:
i) The youth suffers from a mental illness or
mental disorder; and
ii) The
medication is in the medical interest of the youth; and
iii) The youth is either gravely disabled or
poses a likelihood of serious harm to self or others; and
B) The administration of such medication has
been approved by the Treatment Review Committee after a hearing (see subsection
(b) of this Section). However, no such approval or hearing shall be required
when the medication is administered in an emergency situation. An emergency
situation exists whenever the required determinations listed in subsection
(a)(1)(A) of this Section have been made and a psychiatrist, or in the absence
of a psychiatrist a physician, has determined that the youth poses an imminent
threat of serious physical harm to self or others. In all emergency situations,
the procedures set forth in subsection (e) of this Section shall be
followed.
2) Whenever a
physician orders the administration of psychotropic medication to a youth
against the person's will, the physician shall document in the youth's medical
file the facts and underlying reasons supporting the determination that the
standards in subsection (a)(1) of this Section have been met and:
A) The Chief Administrative Officer shall be
notified as soon as practicable; and
B) Unless the medication was administered in
an emergency situation, the Chairperson of the Treatment Review Committee shall
be notified in writing within three days.
b) Treatment Review Committee Procedures
The Treatment Review Committee shall be comprised of two
members appointed by the Chief Administrative Officer, both of whom shall be
mental health professionals and one of whom shall be a physician. One member
shall serve as Chairperson of the Committee. Neither of the Committee members
may be involved in the current decision to order the medication. The members of
the Committee shall have completed a training program in the procedural and
mental health issues involved that has been approved by the Agency Medical
Director.
1) The Chief Administrative
Officer shall designate a member of the program staff not involved in the
current decision to order medication to assist the youth. The staff assistant
shall have completed a training program in the procedural and mental health
issues involved that has been approved by the Agency Medical
Director.
2) The youth and staff
assistant shall receive written notification of the time and place of the
hearing at least 24 hours prior to the hearing. The notification shall include
the tentative diagnosis and the reasons why the medical staff believes the
medication is necessary. The staff assistant shall meet with the youth prior to
the hearing to discuss the procedural and mental health issues
involved.
3) The youth shall have
the right to attend the hearing unless the Committee determines that it is
likely that the youth's attendance would subject the youth to substantial risk
of serious physical or emotional harm or pose a threat to the safety of others.
If such a determination is made, the facts and underlying reasons supporting
the determination shall be documented in the youth's medical file. The staff
assistant shall appear at the hearing whether or not the youth
appears.
4) The documentation in
the medical file referred to in subsection (a)(2) of this Section shall be
reviewed by the Committee and the Committee may request the physician's
personal appearance at the hearing.
5) Prior to the hearing, witnesses identified
by the youth and the staff assistant may be interviewed by the staff assistant
after consultation with the youth as to appropriate questions to ask. Any such
questions shall be asked by the staff assistant unless cumulative, irrelevant,
or a threat to the safety of individuals or the security of the youth
center.
6) Prior to the hearing,
the youth and the staff assistant may request in writing that witnesses be
interviewed by the Committee and may submit written questions for witnesses to
the Chairperson of the Committee. These questions shall be asked by the
Committee unless cumulative, irrelevant, or a threat to the safety of
individuals or the security of the facility. If any witness is not interviewed,
a written reason shall be provided.
7) Prior to the hearing, the youth and the
staff assistant may request in writing that witnesses appear at the hearing.
Any such request shall include an explanation of what the witnesses would
state. Reasonable efforts shall be made to have such witnesses present at the
hearing, unless their testimony or presence would be cumulative, irrelevant, or
a threat to the safety of individuals or the security of the facility, or for
other reasons including, but not limited to, unavailability of the witness or
matters relating to institutional order. In the event requested witnesses are
unavailable to appear at the hearing but are otherwise available, they shall be
interviewed by the Committee as provided for in subsections (b)(6) and (9) of
this Section.
8) At the hearing,
the youth and the staff assistant may make statements and present documents
that are relevant to the proceedings. The staff assistant may direct relevant
questions to any witnesses appearing at the hearing. The youth may request that
the staff assistant direct relevant questions to any witnesses appearing at the
hearing and the staff assistant shall ask such questions unless cumulative,
irrelevant, or a threat to the safety of individuals or the security of the
facility.
9) The Committee shall
make such investigation as it deems necessary. The staff assistant shall be
informed of any investigation conducted by the Committee and shall be permitted
to direct relevant questions to any witnesses interviewed by the Committee. The
staff assistant shall consult with the youth regarding any statements made by
witnesses interviewed by the Committee and shall comply with requests by the
youth to direct relevant questions to such witnesses unless cumulative,
irrelevant, or a threat to the safety of individuals or the security of the
facility.
10) The Committee shall
consider all relevant information and material that has been presented in
deciding whether to approve administration of the medication.
11) A written decision shall be prepared and
signed by all members of the Committee that contains a summary of the hearing
and the reasons for approving or disapproving the administration of the
medication. Copies of the decision shall be given to the youth, the staff
assistant, and the Chief Administrative Officer. Any decision by the Committee
to approve involuntary administration of psychotropic medication must be
unanimous. The Chief Administrative Officer shall direct staff to comply with
the decision of the Committee.
12)
If the Committee approves administration of the medication, the youth shall be
advised of the opportunity to appeal the decision to the Agency Medical
Director by filing a written appeal with the Chairperson within five days after
the youth's receipt of the written decision.
c) Review by Agency Medical Director
1) If the youth appeals the Treatment Review
Committee's decision, staff shall continue to administer the medication as
ordered by the physician and approved by the Committee while awaiting the
Agency Medical Director's decision on the appeal.
2) The Chairperson of the Committee shall
promptly forward the written notice of appeal to the Agency Medical Director or
a physician designated by the Agency Medical Director.
3) Within five working days after receipt of
the written notice of appeal, the Agency Medical Director shall:
A) Review the Committee's decision, make such
further investigation as deemed necessary, and submit a written decision to the
Chief Administrative Officer; and
B) Provide a copy of the written decision to
the youth, the staff assistant, and the Chairperson of the Committee.
4) The Chief Administrative
Officer shall direct staff to comply with the decision of the Agency Medical
Director.
d) Periodic
Review of Medication
1) Whenever any youth has
been involuntarily receiving psychotropic medication continuously or on a
regular basis for a period of six months, the administration of such medication
shall, upon the youth's written request, be reviewed by the Treatment Review
Committee in accordance with the procedures enumerated in subsections (b) and
(c) of this Section. Every six months thereafter, for so long as the
involuntary medication continues on a regular basis, the youth shall have the
right to a review hearing upon written request.
2) Every youth who is involuntarily receiving
psychotropic medication shall be evaluated by a psychiatrist at least every 30
days, and the psychiatrist shall document in the youth's medical file the basis
for the decision to continue the medication.
e) Emergency Procedures
Subsequent to the involuntary administration of psychotropic
medication in an emergency situation:
1) The basis for the decision to administer
the medication shall be documented in the youth's medical file and a copy of
the documentation shall be given to the youth and to the Agency Medical
Director for review.
2) A mental
health professional shall meet with the youth to discuss the reasons why the
medication was administered and to give the youth an opportunity to express any
concerns he or she may have regarding the medication.
f) Documentation
Copies of all notifications and written decisions shall be
placed in the youth's medical file.
g) Grievances
A youth may submit a grievance concerning the involuntary
administration of psychotropic medication directly to the Administrative Review
Board in accordance with 20 Ill. Adm. Code 2504.Subpart F. In considering the
grievance, the Board shall confer with the Agency Medical
Director.
h) Treatment of
Minors
In the case of a youth who is a minor under the age of 18, the
parent or guardian shall be sent the documentation and written decisions that
are provided to the youth pursuant to this Section and shall be permitted to
attend and participate in any proceedings required by this Section. Notice of
any Treatment Review Committee hearing shall be promptly sent to the parent or
guardian and reasonable attempts shall be made to provide such notice at least
72 hours prior to the hearing.